Faculty Bibliography

In 2012, fast-food companies spent $4.6 billion on ads, while $116 million was spent advertising fruits and vegetables. Because young people see tons of food ads on adult-targeted programs, it makes sense to cite the whole $4.6 billion figure

[...]because of the 'terrible choice' Medicare rules impose, hospice is not doing end-of-life care as much as brink-of-death care."

Wilderness and other protected areas provide myriad benefits to Utahns, including clear air and water, places to recreate and spiritual value. [...]it's determined which of the lands under BLM management are indeed wilderness, a transfer of the magnitude being considered in this report is nothing short of a Faustian bargain

Vaccines are among the most cost-effective interventions against infectious diseases. Many candidate vaccines targeting neglected diseases in low- and middle-income countries are now progressing to large-scale clinical testing. However, controversy surrounds the appropriate design of vaccine trials and, in particular, the use of unvaccinated controls (with or without placebo) when an efficacious vaccine already exists. This paper specifies four situations in which placebo use may be acceptable, provided that the study question cannot be answered in an active-controlled trial design; the risks of delaying or foregoing an efficacious vaccine are mitigated; the risks of using a placebo control are justified by the social and public health value of the research; and the research is responsive to local health needs. The four situations are: (1) developing a locally affordable vaccine, (2) evaluating the local safety and efficacy of an existing vaccine, (3) testing a new vaccine when an existing vaccine is considered inappropriate for local use (e.g. based on epidemiologic or demographic factors), and (4) determining the local burden of disease.

BACKGROUND: The emerging field of stem cell-based aesthetics has raised ethical concerns related to advertising campaigns and standards for safety and efficacy. OBJECTIVES: The authors sought to characterize the attitudes of plastic surgeons regarding the ethics of stem cell-based aesthetics. METHODS: A cross-sectional electronic survey was distributed to 4592 members of the American Society for Aesthetic Plastic Surgery and the American Society of Plastic Surgeons. Statements addressed ethical concerns about informed consent, conflicts of interest, advertising, regulation, and stem cell tourism. An agreement score (AS) from 0 to 100 was calculated for each statement. Majority agreement was designated as >/=60 and majority disagreement as